Literature DB >> 19775213

Prevalence of acute mountain sickness in the Eastern Alps.

Klemens Mairer1, Maria Wille, Thomas Bucher, Martin Burtscher.   

Abstract

Little information is available on the prevalence of acute mountain sickness (AMS) in the Eastern Alps compared with the Western Alps. Because of differences regarding the populations of mountaineers, we hypothesized that the prevalence differs between the Eastern and Western Alps. Thus, we determined the prevalence and risk factors of AMS at four different altitudes in the Eastern Alps of Austria. Four hundred and thirty-one recreational hikers were studied using questionnaires on the morning of their first night at high altitude. A diagnosis of AMS was based on a Lake Louise Score > or =4, the presence of headache, and at least one additional symptom. Overall 16.2% of the subjects met the criteria for AMS, and the prevalence of AMS increased significantly with altitude (2200 m: 6.9%; 2500 m: 9.1%; 2800 m: 17.4%; 3500 m: 38.0%). Heavy perceived exertion, a history of migraine, the absolute altitude reached, little mountaineering experience, and inadequate water intake (< or =2 L) were independent AMS risk factors. The reported altitude-related AMS prevalence in the Western Alps is 4% to 8% lower compared with that found in this study for the Eastern Alps. In conclusion, the prevalence of AMS is higher in the tourist population of the Eastern Alps compared to the more experienced mountaineers of the Western Alps. Consideration of easily modifiable risk factors such as individual exertion and water intake could markedly reduce AMS and contribute to the enjoyment of mountaineering.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19775213     DOI: 10.1089/ham.2008.1091

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  19 in total

Review 1.  Short-term exposure to hypoxia for work and leisure activities in health and disease: which level of hypoxia is safe?

Authors:  Martin Burtscher; Klemens Mairer; Maria Wille; Hannes Gatterer; Gerhard Ruedl; Martin Faulhaber; Günther Sumann
Journal:  Sleep Breath       Date:  2011-04-16       Impact factor: 2.816

2.  Acetazolamide pre-treatment before ascending to high altitudes: when to start?

Authors:  Martin Burtscher; Hannes Gatterer; Martin Faulhaber; Johannes Burtscher
Journal:  Int J Clin Exp Med       Date:  2014-11-15

3.  Resting arterial oxygen saturation and breathing frequency as predictors for acute mountain sickness development: a prospective cohort study.

Authors:  Martin Faulhaber; Maria Wille; Hannes Gatterer; Dieter Heinrich; Martin Burtscher
Journal:  Sleep Breath       Date:  2014-01-17       Impact factor: 2.816

4.  Association between body water status and acute mountain sickness.

Authors:  Hannes Gatterer; Maria Wille; Martin Faulhaber; Henry Lukaski; Andreas Melmer; Christoph Ebenbichler; Martin Burtscher
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

Review 5.  Non-high altitude methods for rapid screening of susceptibility to acute mountain sickness.

Authors:  Han Song; Tao Ke; Wen-Jing Luo; Jing-Yuan Chen
Journal:  BMC Public Health       Date:  2013-09-30       Impact factor: 3.295

6.  Risk prediction score for severe high altitude illness: a cohort study.

Authors:  Florence Canouï-Poitrine; Kalaivani Veerabudun; Philippe Larmignat; Murielle Letournel; Sylvie Bastuji-Garin; Jean-Paul Richalet
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

7.  Rhodiola crenulata extract for prevention of acute mountain sickness: a randomized, double-blind, placebo-controlled, crossover trial.

Authors:  Te-Fa Chiu; Lisa Li-Chuan Chen; Deng-Huang Su; Hsiang-Yun Lo; Chung-Hsien Chen; Shih-Hao Wang; Wei-Lung Chen
Journal:  BMC Complement Altern Med       Date:  2013-10-31       Impact factor: 3.659

8.  Association between smoking and the risk of acute mountain sickness: a meta-analysis of observational studies.

Authors:  Chen Xu; Hong-Xiang Lu; Yu-Xiao Wang; Yu Chen; Sheng-Hong Yang; Yong-Jun Luo
Journal:  Mil Med Res       Date:  2016-12-08

9.  MRI evidence: acute mountain sickness is not associated with cerebral edema formation during simulated high altitude.

Authors:  Klemens Mairer; Markus Göbel; Michaela Defrancesco; Maria Wille; Hubert Messner; Alexander Loizides; Michael Schocke; Martin Burtscher
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  Acute mountain sickness among tourists visiting the high-altitude city of Lhasa at 3658 m above sea level: a cross-sectional study.

Authors:  Per Nafstad; Hein Stigum; Tianyi Wu; Øyvind Drejer Haldorsen; Kristoffer Ommundsen; Espen Bjertness
Journal:  Arch Public Health       Date:  2016-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.